It is known from reductionist antigen models using adoptive T cell transfer that binding affinities between antigenic peptides and MHC class I as well as the binding affinity of the peptide/MHC complex to the corresponding TCR are critical determinants of tumor-directed T cell reactivity and the capability of T cells to reject a tumor (46, 47). Here, HLA-C is linked to neoplasm.